HealthLeaders Media October 4, 2022
Illumina’s partners say they believe the company will continue to improve the speed and continue to lower the price.
KEY TAKEAWAYS
– Along with speed and cost, Illumina – which controls about 80% of the global genome sequencing market — says the NovaSeq X also reduces packaging waste and weight by 90% and cuts plastic use in half when compared to NovaSeq 6000.
– Ambient-temperature shipping of reagents will also eliminate the need for nearly 500 tons of dry ice each year and waste for customers. Illumina will begin to distribute the NovaSeq™ X Series machines in 2023
San Diego-based Illumina, Inc., has launched a “production scale” sequencer that it claims can process human genomes in half a day for...
Today's Sponsors
Today's Sponsor